MRK vs NYT · P/E 33, rev $16.61B vs P/E 32, rev $762.5M
Merck & Company Inc (MRK) versus New York Times Company (NYT) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
New York Times Company (NYT) is a publishing company listed on NYSE.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported NYT revenue for 2026-06-30 was $762.5M. Net income was $93.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. NYT currently screens at market cap $12.05B and trailing P/E 32.0.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. NYT currently screens at market cap $12.05B and trailing P/E 32.0.
Not investment advice. Open the MRK and NYT stock pages for the full models.
Not investment advice.